Achieving Better Advocacy Group Relationships, a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

JEFF ZIMMER | February 3, 2017

article image
When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. For decades, disease awareness campaigns were a part of the playbook for educating physicians and patients about new products. But, awareness programs receded in the long shadow cast by Direct-to-Consumer (DTC) marketing after the FDA, in 1985, explicitly allowed TV drug advertising.

Spotlight

Medical Devices Alliance

We provide a fresh, dynamic approach to effectively developing products for companies in the medical device and pharmaceutical industries. We are an Alliance of industry professionals experienced across the life cycle of medical devices and combination products. We offer an alternative development route to help clients get medical devices to market efficiently.

OTHER ARTICLES

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | March 2, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Spotlight

Medical Devices Alliance

We provide a fresh, dynamic approach to effectively developing products for companies in the medical device and pharmaceutical industries. We are an Alliance of industry professionals experienced across the life cycle of medical devices and combination products. We offer an alternative development route to help clients get medical devices to market efficiently.

Events